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Bunyaviruses are considered to be emerging pathogens facil-
itated by the segmented nature of their genome that allows reas-
sortment between different species to generate novel viruses
with altered pathogenicity. Bunyaviruses are transmitted via a
diverse range of arthropod vectors, as well as rodents, and have
established a global disease range with massive importance in
healthcare, animal welfare, and economics. There are no vac-
cines or anti-viral therapies available to treat human bunyavirus
infections and so development of new anti-viral strategies is
urgently required. Bunyamwera virus (BUNV; genusOrthobun-
yavirus) is the model bunyavirus, sharing aspects of its molecu-
lar and cellular biology with all Bunyaviridae family members.
Here, we show for the first time that BUNV activates and
requires cellular potassium (K) channels to infect cells. Timeof
addition assays using K channel modulating agents demon-
strated thatK channel function is critical to events shortly after
virus entry but prior to viral RNA synthesis/replication. A sim-
ilar K channel dependence was identified for other bunyavi-
ruses namely Schmallenberg virus (Orthobunyavirus) as well as
the more distantly related Hazara virus (Nairovirus). Using a
rational pharmacological screening regimen, two-pore domain
K channels (K2P) were identified as the K channel family
mediating BUNVK channel dependence. As several K2P chan-
nel modulators are currently in clinical use, our work suggests
theymay represent a newand safe drug class for the treatment of
potentially lethal bunyavirus disease.
The Bunyaviridae family represents the largest taxonomic
grouping of negative sense RNA viruses, with over 350 named
members (1). The family is divided into five genera,Orthobun-
yavirus, Hantavirus, Tospovirus, Phlebovirus, and Nairovirus
and takes its name from Bunyamwera virus (BUNV),3 the pro-
totype of the genus Orthobunyavirus.
All bunyaviruses share common elements of virion structure
being enveloped and containing an RNA genome that com-
prises three separate RNA segments named small (S), medium
(M), and large (L). These three segments encode four structural
proteins using an expression strategy that is conserved across
all members of the family: the S segment encodes the nucleo-
protein (N), theM segment encodes two glycoproteins (Gn and
Gc), and the L segment encodes an RNA-dependent RNA po-
lymerase (L protein). Most Bunyaviridae family members
including BUNV also encode two non-structural proteins; NSs
from the S segment, and NSm from the M segment (2, 3).
Bunyaviruses are predominantly arthropod-borne viruses
capable of infecting a wide range of hosts including humans,
plants, and animals. Four of the five bunyavirus genera include
members that are associated with lethal hemorrhagic fevers in
infected humans, and many are considered to be emerging
pathogens due to a complex combination of factors including
travel, animal trade, and climate change (4–6). Bunyavirus
emergence is facilitated by the segmented nature of their
genome that allows reassortment between different species to
generate novel viruses with altered pathogenicity (7). Schmal-
lenberg (SBV) and Ngari (NGAV) viruses are orthobunyavi-
ruses that exemplify this phenomenon; NGAV, which causes a
highly fatal hemorrhagic fever in humans (8) is a reassortant
possessing S and L segments from BUNV and the M segment
from the closely related Batai virus (BATV) (9). Similarly, SBV,
which is a pathogen responsible for teratogenic disease in sheep
and cattle (10), has a complex genetic background possessing
segments shared with previously characterized Sathuperi and
Shamonda viruses (11). The threat of widespread arthropod
borne transmission of these potentially lethal emerging viruses
means the development of preventative and therapeutic strat-
egies is urgently required.
One strategy to identify new anti-viral therapies is to target
virus host interactions that are essential for virus multiplica-
tion. Many examples of such interactions have been described
for bunyaviruses (reviewed in Refs. 12, 13) and other recent
examples include those involved in virus entry (14), counteract-
ing the antiviral response (15–17) and modulating host gene
expression (16, 18). Another group of potential targets are host
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cell ion channels, which regulate ion homeostasis across all cel-
lular membranes and are key players in a broad and extensive
range of cellular processes including the cell cycle, gene expres-
sion, cell signaling, and innate immunity (19–21). Ion channels
are emerging as key factors required during virus replicative
cycles, and have been assigned critical roles in virus entry, sur-
vival, and release. Examples include roles for both potassium
(K) and chloride ion (Cl) channels during the hepatitis C
virus lifecycle (22, 23), the ability of human immunodeficiency
virus proteins to modulate K channel activity (24, 25) and the
recently identified requirement of two-pore calcium (Ca2)
channels (TPCs) in endosomal membranes for successful entry
of Ebola virus (26). Here, we report that BUNV multiplication
depends on the function of cellular K channels. Using the
available ion channel pharmacological tools, a small family of
two-pore potassium ion channels (K2P) was identified as the
candidate K channel family critical for BUNVmultiplication.
We propose that targeting K channel function may represent
a new, pharmacologically safe and broad ranging therapeutic
strategy for this important family of pathogens.
Experimental Procedures
Cells and Viruses—A549 (adenocarcinomic human alveolar
basal epithelial cells) and Vero (African green monkey kidney
cell lines) cells were obtained from the European Collection of
Cell Cultures (ECACC) and maintained at 37 °C in Dulbecco’s
modified Eagle’s medium (DMEM-Sigma) supplemented with
10% fetal bovine serum (FBS), 100 units/ml penicillin and 100
g/ml streptomycin. Huh7 cells (hepatocyte derived cellular
carcinoma cell line) were a gift from R. Bartenschlager (Heidel-
berg University) and maintained under these conditions but
additionally supplemented with non-essential amino acids.
BSRT-7 cells (derived from BHK21 cells, that constitutively
express bacteriophage T7 polymerase) were obtained from
K. K. Conzelmann (University of Munich) (27) and maintained
under these conditions but additionally supplemented with
G418 (100g/ml). U87-MGcells (a human glioblastoma-astro-
cytoma, epithelial-like cell line) were obtained from the
ECACC and grown in minimal essential Eagle’s medium
(MEM) supplemented with 10% FBS, 1 mM sodium pyruvate, 1
mM non-essential amino acids, 2 mM L-glutamine, penicillin G
(100 units/ml), and streptomycin (100 g/ml). All mammalian
cells were incubated in a humidified incubator at 37 °C in the
presence of 5% CO2. Ae. albopictus C6/36 cells (a gift from L.
Alphey, University of Oxford) were grown at 28 °C in Leibo-
vitz’s 15medium (Sigma) supplemented with 10% FBS and 10%
tryptose phosphate broth. Working stocks of wild-type BUNV
(provided by R. Elliot, Glasgow Centre for Virus Research) was
prepared as described previously (28). HAZV (strain JC280,
ECACC) was propagated in SW13 cells (human adrenal cortex
carcinoma cell line, ECACC) and clarified supernatants were
used to infect A549 cells. The titer of infectious HAZV was
estimated by plaque assay; typical yields from virus propagation
experiments were between 1 105 and 1 107 plaque forming
units per ml (pfu/ml). Human RSV strain A2 (subgroup A,
ECACC) was passaged through HEp-2 cells (human cervix car-
cinoma cell line, ECACC) and purified by sucrose density gra-
dient according to previously described protocols (29). Viral
titers were accurately determined in HEp-2 cells by a modified
methylcellulose-based plaque assay with immunostaining
using goat anti-hRSV antibodies (Abcam). SBV (strain BH80/
11-4 provided by M. Beer, Friedrich-Loeffler Institute) was
propagated in Vero cells in the presence of 2% FBS.
Drug Treatments—For the assessment of BUNV infection,
1  105 cells/well were seeded into 6-well plates and allowed
24 h to settle. Where indicated, cells were pre-incubated with
the specific ion channel modulator for 45 min, or medium sup-
plemented with the solvent control of each channel modulator,
prior to and during virus infection. Cells were infected at an
MOI of 1 for 24 h.
Assessment of Virus Production by Western Blot Analysis—
BUNV-N protein expression was assessed using the following
method. Infected cells were lysed inGLB buffer (25mMglycerol
phosphate, 20 mM Tris, 150 mM NaCl, 1 mM EDTA, 1% Triton
X-100, 10% glycerol, 50 mM NaF) plus protease inhibitors
(Complete; Roche). Cell lysates (50g of protein) were normal-
ized by BCA assay and resolved by SDS-PAGE, transferred to a
PVDF membrane (Millipore) using a Bio-Rad Laboratories
semidry transfer apparatus, and probed with a sheep BUNV-N
serum followed by labeling with anti-sheep HRP-conjugated
secondary antibodies (Sigma). All Western blots were visual-
ized using ECL system (Advansta). HAZV-N expression was
assessed using a sheep HAZV-N serum before labeling with
anti-sheep HRP conjugated secondary antibodies (Sigma). For
HRSV staining, cells were labeledwith goat anti-hRSV antibod-
ies (Abcam) and anti-goat HRP-conjugated secondary antibod-
ies (Pierce).
Immunofluorescent Analysis—For the assessment of BUNV
infection, infected cells grown on polylysine-coated glass cov-
erslips were fixed with methanol for 10 min, permeabilized in
ice-cold methanol/acetone for 10 min, and blocked in PBS/1%
BSA for 30 min. For BUNV-N protein staining, cells were
labeled with sheep anti-BUNV-N serum before staining with
sheep Alexa Fluor 594 nm conjugated anti-sheep secondary
antibodies (Invitrogen-Molecular Probes) in PBS/1% BSA.
Cells were washed and mounted onto microscope slides using
prolong gold containing DAPI (Invitrogen-Molecular Probes).
Labeled cells were viewed on an inverted Zeiss 510-META
laser-scanning confocalmicroscope under an oil-immersion 40
or 63 objective lens (NA 1.40). Alexa Fluor 594 nm (550 nm
excitation, 570 nm emission) was excited using a helium/neon
laser fitted with 543 nm filters. Displayed images are represen-
tative of at least three independent experiments and displayed
as single optical sections of 50m thickness. Randomly chosen
fields were observed under fluorescence microscopy to assess
virus staining and the number of virus-positive cells quanti-
tated for 100 cells per condition using ImageJ software as
previously described (30). Results are presented asmeans S.E.
from a minimum of three independent experiments. For
HAZV-N staining, cells were labeled with sheep anti-HAZV-N
serum before staining with sheep Alexa Fluor 594 nm conju-
gated anti-sheep secondary antibodies. For hRSV staining cells
were labeled with goat anti-hRSV antibodies (Abcam) and
stained with goat Alexa Fluor 594 antibodies (Invitrogen-Mo-
lecular Probes). For the assessment of endogenous K2P channel
expression, fixed A549 cells were labeled with anti-KCNK 1, 2,
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7, or 9 antibodies (Santa Cruz Biotechnology Inc) and stained
with the appropriate Alexa Fluor 488/594 antibodies (Invitro-
gen-Molecular Probes).
Time-course Assays—BUNV infected cells were treated with
TEA (10 mM) or quinidine (200 M) in the medium during the
24 h infection period (T 0), or added 1, 2, 4, 6, 8, and 10 hpi.
Virus infection was allowed to proceed for a total of 24 h, and
cells were lysed forWestern blot analysis. For the assessment of
BUNV entry, A549 cells were treated during the initial 1h
of BUNV infection with TEA (10 mM) or monensin (20 M).
BUNV virions that were not internalized were washed off with
0.5% trypsin in PBS (3). Medium was then replaced, and the
cells incubated for 24 h before analysis.
BUNV Growth Assays—BUNV was propagated in Vero cells
in DMEM containing 2% FBS. Culture supernatants were har-
vested when 90% cytopathic effect (CPE) was observed and
passed through a 0.45 m syringe filter to removed cellular
debris. For virus inhibition experiments, growth medium was
removed from Vero cells and replaced with 2% FBS DMEM,
supplemented with the appropriate drug dilution, for 1 h at
37 °C.Mediumwas transferred to empty plates while cells were
incubated for 1 h at 37 °C with serum-free medium (Mock) or
serum-free medium containing 500 TCID50/ml BUNV (MOI
0.025). Medium was discarded and drug containing-medium
was returned, and cells incubated for 5 days. Cells were washed
and fixed in 100% ethanol for 30 min at room temperature
before staining with 3% (w/v) crystal violet for 1 h at room
temperature.
BUNV Transcription/Replication—A549 cells were infected
with BUNV (MOI 1) and either treated with TEA (10 mM), or
left untreated. At 1, 6, or 24 hpi, total cell RNA were harvested
using an RNeasy kit (Qiagen). RNA from mock-infected A549
cells was also harvested. All RNAs were subjected to primer
extension analysis as previously described (31), using 33P end-
labeled oligonucleotide primer P-ext (5	-GAGCCTTTAATG-
ACCTTCTGTTGG-3	) designed to anneal to nucleotides
58–81 of the BUNV S segment anti-genome. Extension prod-
ucts were separated by 6% denaturing PAGE, and visualized
using autoradiography. BUNV replicon assays were performed
as previously described (12, 31). Briefly, BSRT7 cells were trans-
fected with cDNA plasmids encoding BUNV S and L segment
open reading frames (ORFs), and a model negative sense RNA
segment that contained conserved BUNV 3	 and 5	 non-trans-
lated regions flanking the Renilla luciferase ORF. Cells were
incubated with or without TEA (5 or 10 mM) for 18 h and lysed
in passive lysis buffer (Roche). Cell lysates were analyzed for
luciferase activity (relative luminescence units (RLU) per sec-
ond) as a measure of BUNV gene expression. The L ORF plas-
mid was omitted and replaced with GFP to act as a negative
control tomeasure non-BUNVmediated luciferase expression.
Results were normalized to those for an untreated control.
Error bars represent the standard errors of the means (S.E.) of
results from three independent experiments performed in
duplicate.
Resting Membrane Potential Assay—Cells were treated with
20 M DiBAC4(3) (Sigma) in medium for 20 min at 37 °C and
protected from light. Conditions were selected as optimal
from standardization of DiBAC4(3) concentrations, incuba-
tion time, and temperature. Following labeling, cells were
washed and either mock-infected or infected with BUNV
(MOI 1). Cells were treated with TEA (10 mM) or quinidine
(200 M) as controls. The average mean intensity of green
fluorescence GCU (Green Calibration Units per well) was
measured from several widefield images using IncuCyte
ZOOM live cell imaging at 1-h intervals for up to 6 h. Values
are presented as the mean fluorescent intensity per cell nor-
malized to untreated controls from aminimumof three inde-
pendent experiments. Assays of [Cl]i using 5 mM 6-me-
thoxy-quinolyl acetoethyl ester (MQAE) were performed as
previously described (22). 5-Nitro-1–3-phenylpropylamino
benzoic acid (NPPB) and indyanyloxyacetic acid 94 (IAA-94)
were included as compounds known to modulate Cl func-
tion for assay verification.
K2P Channel RT-PCR—Total cell RNA was extracted from
A549 cells and reverse transcribed under the following condi-
tions: 3 min 94 °C; 30 cycles, 45 s 94 °C, 30 s 55 °C, and 90 s
72 °C; final extension 10min 72 °C. Primers for KCNK1–17 are
available on request. PCR products were resolved on 2% aga-
rose gels.
Statistical Analyses—The statistical significance of data were
determined by performing a Student’s t test or one way
ANOVA test. Significance was deemed when the values were
less than or equal to the 0.05 p value.
Results
K Channels Are Required for BUNV Infection—To deter-
mine if the activity of host cell K channels are required during
the bunyavirus lifecycle, BUNV infection assays were per-
formed in the presence of broad-spectrum K channel modu-
lators used at pharmacologically relevant concentrations.
BUNV growth was assessed through detecting the expression
of the BUNV nucleoprotein (BUNV-N); known to correlate
with virus production (28). Tetraethylammonium (TEA), a
broad spectrumK channel blocker, inhibited BUNV infection
at concentrations2 mM (Fig. 1, A and B). A similar effect was
seen when extracellular KCl was increased above 20mM (Fig. 1,
A and B) to collapse K gradients and inhibit K channel activ-
ity. Any non-K channel effects due to the off target effects of
these compounds were ruled out as a second K salt K2S04
similarly inhibited BUNV-Nproduction at concentrations20
mM (32–37). These data were confirmed when the percentage
of BUNV-infected cells was assessed by analysis of immunoflu-
orescence staining for BUNV-N (TEA 73.85% 15.3 reduc-
tion p 0.05, KCl 82.32% 13.2 reduction p 0.05, K2S04
94.20% 5.0 reduction p 0.05), (Fig. 1, B andC, gray bars). At
the concentrations assessed, all compounds were non-toxic as
confirmedbyATPliteTMviability assays (Fig. 1D (ii) black bars).
To further confirm the findings, the effects of K channel inhi-
bition were assessed on the accumulated RNA products of
either BUNVmRNA transcription or genome replication using
primer extension (Fig. 1E). At the 24 h time point, extension
products corresponding to BUNV mRNA transcripts and
BUNV anti-genomic RNAs were detectable in BUNV-infected
cells. In contrast, extension products were undetectable in
BUNV-infected cells treated with TEA (Fig. 1E, compare lanes
4 and 7). Taken together, these data indicate a specific require-
K Channels Are Required for BUNV Infection
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ment for K channel function during the BUNV replicative
cycle.
K Channel Dependence Is Conserved Across Invertebrate
and Vertebrate Cell Types—As expected from its arthropod-
borne transmission to a variety ofmammalian hosts, BUNVcan
replicate in a range of vertebrate and invertebrate cell lines (3,
4). The dependence of BUNV on K channel function was
therefore assessed in a range of cell types. Vero (monkey kidney
cells) U87-MG (human glioblastoma cells), Huh7 (human hep-
atocellular carcinoma cells) supported BUNV infection, as evi-
denced by robust BUNV-N expression (Fig. 2A), which was
inhibited by the addition of TEA and KCl. To rule out the pos-
sibility of the observed inhibition being restricted to BUNV-N
expression, the effects of K channel inhibition on virus infec-
tion and spread was assessed. BUNV induces extensive cyto-
pathic effect (CPE) in Vero cells resulting in the formation of
plaques under solid culture or the destruction of themonolayer
under liquid culture. In untreated Vero cells infected with
BUNV at a low MOI (0.025), the cytopathic effect (CPE) was
so extensive after 5 days of culture that no cell monolayer was
present to take up stain (Fig. 2B). In contrast, treatment of
BUNV-infected cells with 30 mM KCl abrogated virus-in-
duced CPE, confirming that K channel modulation inhibits
BUNV production. Numerous K channels are expressed in
insect cells (38, 39). IndeedDrosophilaATP-sensitive K chan-
nels have been demonstrated tomediate resistance to a cardiotro-
pic RNA virus, flock house virus (40). The effects of K inhibition
onBUNV infectionwere therefore assessed inC6/36 (Ae. albopic-
tus cells) as a representative cell line for the BUNVarthropod host
(41). BUNV-N production was highly sensitive to K channel
blockade as TEA 2 mM and KCl 20 mM inhibited BUNV-N
production to almost undetectable levels (Fig. 2C). These data
FIGURE 1. K channel inhibition impedes BUNV infection. A, representative Western blots from BUNV-infected A549 cells (24 h, MOI 1) treated with
the indicated K (TEA, KCl, K2S04), channel blockers. Lysates were resolved by SDS-PAGE and probed with sheep anti-BUNV N serum (n 3). Blots were
reprobed for GAPDH as a loading control. B, densitometry of Western blots from Fig. 1A from TEA (10 mM), KCl (40 mM), K2S04 (40 mM), performed using
ImageJ. Signals were normalized to BUNV infected, no-drug controls (n 3). Results are expressed asmean S.E. (*, significant difference at the p 0.05
level; NS, not significant. C, cells plated onto coverslips were treated with TEA (10mM), KCl (20mM), K2S04 (20mM), and BUNV infected for 24 h. Cells were
fixed, permeabilized, and stained for BUNV-N (red) and DAPI (blue) using sheep anti-BUNV-N serum and sheep Alexa-fluor 594 antibodies. D, % of
BUNV-infected cells was assessed for each treatment from widefield images of BUNV-N stained cells (gray bars). A minimum of 100 cells were counted.
Results are expressed as mean S.E. (*, significant difference at the p 0.05 level; NS, not significant). A549 cells were treated as above and cell viability
assessed via ATPlite assays (black bars). Values are normalized to untreated controls. E, A549 cells were infected 10 mM TEA and RNA were extracted
at the indicated time points and subjected to primer extension analysis to quantify S segment anti-genomes and mRNAs using 33P end-labeled primer
P-ext. The position at which P-ext annealed to BUNV specific positive sense RNAs is shown schematically. Resulting extension products were analyzed
by denaturing 6% PAGE and visualized by autoradiography.
K Channels Are Required for BUNV Infection
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confirmed that BUNV infection of both mammalian and mos-
quito cells is similarly inhibited by K channel modulation.
K Channel Dependence Is Bunyavirus Specific—The diver-
sity within bunyaviruses is revealed by their division into five
distinct genera. To assess whether growth of other bunyavi-
ruses exhibited similar dependence on K channel activity,
Hazara virus (HAZV); a member of theNairovirus genus, and a
close relative of the highly pathogenic hazard group 4 virus
Crimean Congo hemorrhagic fever virus (CCHFV; Ref. 42) was
assessed. HAZV was similarly inhibited in the presence of
TEA 2 mM, as judged by a clear decrease in the abundance of
HAZV-N protein and the reduction of the number of HAZV
infected cells treated with TEA, (Fig. 3A, 59.97% reduction 
20.37 p  0.05). Production of the orthobunyavirus SBV was
also sensitive to K channel inhibition through KCl treatment.
Treatment of SBV-infected Vero cells with30 mM KCl abro-
gated SBV-induced CPE in a manner identical to BUNV (Fig.
3B). To investigate if K channel sensitivity occurs during the
replicative cycle of other unrelated negative sense RNA virus
families, human respiratory syncytial virus (hRSV), a non-seg-
mented RNA virus of the family Paramyxoviridaewas assessed
under identical conditions of TEA treatment. Unlike ribavirin,
which was strongly inhibitory to hRSV production as expected
from previous work (43), A549 cells treated with TEA concen-
trations of 5 or 10 mM could support hRSV infection as evi-
denced by hRSV protein production and the comparable num-
bers of hRSV infected cells compared with no-drug controls,
(Fig. 3C, p  0.05). The fact that hRSV infection levels were
identical to untreated controls in the face of K modulation
ruled out any effects of K channel inhibition on general cell/
virus metabolic processes. Similarly we have previously
reported that bothTEA andKCl do not impact hepatitis C virus
replication at these concentrations in Huh7 cells, which were
permissive to BUNV infection (Fig. 2), (22). Taken together,
these data indicate a specific process during the bunyavirus
lifecycle is impeded by K channel inhibition.
K Channel Function Is Required at an Early Stage of BUNV
Infection—The stage of the BUNV lifecycle that requires K
channel activity was next investigated. To assess the earliest
events of virus infection, A549 cells were incubatedwith BUNV
in the presence of TEA (10mM) for 1 h at 37 °C. Virus/drug was
then removed and the cells incubated for a further 24 h to allow
infection to proceed (Fig. 4A, i and ii) respectively). Monensin
(20 M), an inhibitor of clathrin-mediated endocytosis (CME),
was included in the 1-h treatment as a positive control (44).
Under these conditions, TEA had no impact on BUNV attach-
ment/entry compared with the untreated cells (Fig. 4A (i) lanes
2 and 3, p 0.05). In contrast, CME inhibition with monensin
significantly impeded BUNV entry (Fig. 4A (i-ii), 60.27% 
20.23 reduction in BUNV-N, p 0.05). This strongly suggested
that K channel inhibition does not inhibit BUNV infection at
the stage of virus entry. To observe later lifecycle events, time-
of-addition experiments were performed. Cells were infected
for 60 min and washed, and incubation continued at 37 °C for
24 h in the presence of TEA added at defined timepoints post-
infection. When TEA was added 1–2 h post infection (hpi),
BUNV-N expressionwas not detected (Fig. 4B, compare lanes 1
and 2–4). BUNV-N expression began to recover when treat-
ment was delayed to 4 hpi, and was unaffected when treatment
was initiated at 6 hpi. Thus, BUNV replication is restricted by
synchronous or early treatment with K channel blockers ( 4
hpi) but not by treatment at later timepoints when virus gene
expression has been initiated ( 6 hpi). From the observed
kinetics of virus inhibition it was not clear whether the virus
was inhibited at a stage of entry/uncoating or the initial steps of
virus replication. The effects of TEA on BUNV-specific mRNA
transcription and RNA replication (events that take place fol-
lowing uncoating of BUNV in the cytoplasm and subsequent
release of the ribonucleoprotein (RNP) particles) were assessed
using artificial BUNV minigenome assays, containing Renilla
luciferase as a reporter (45). This approach allowed the assess-
ment of BUNV-specific RNA synthesis independently from
virus entry stages, as all components of the replicon assay are
delivered by plasmid transfection, thus circumventing initial
stages of the BUNV lifecycle. TEAdid not affect these processes
with similar levels of BUNV transcription observed between
untreated versus TEA (5 or 10 mM) treated cells (Fig. 4D, p 
0.05). This confirmed that the K channel-dependent effect
during BUNV infection occurs at a post-entry stage that is prior
to viral RNA synthesis.
BUNV Enhances Cellular KChannel Activity—As BUNV is
dependent on K channel activity during the early stages of the
virus lifecycle, its ability to modulate the functionality of these
channels was assessed. K channels play a crucial role in setting
the resting membrane potential (the charge difference across
the cell membrane). The membrane potential can either
become more negative (hyperpolarization) or more positive
(depolarization) compared with the resting potential as various
ion channels open. In general, the activation of K channels
would be expected to cause hyperpolarization that can bemon-
itored using a membrane potential-sensitive dye, bis (1,3-dibu-
tylbarbituric acid) trimethine oxonol; DiBAC4(3)) (46). Influx
of DiBAC4(3) and an increase in fluorescence indicates cell
depolarisation, while hyperpolarization is indicated by a
FIGURE 2. K channel dependence is conserved across invertebrate and
vertebrate cell types.A, indicatedmammalian cell lineswere treatedwith40
mM KCl or 10 mM TEA and infected with BUNV (24 h, MOI 1). BUNV-N produc-
tion was assessed as in Fig. 1A. B, Vero cells were infected with 500 TCID50/ml
BUNV in thepresenceof KCl or TEA for 5days. Cellswere fixed in100%ethanol
and stained with 3% (w/v) crystal violet. Representative plates of three inde-
pendent experiments are shown. C, C6/36 Ae. albopictus cells were treated
with the indicated concentrations of TEA and KCl and infected with BUNV in
an identical procedure to A. Blots were reprobed for -actin as a loading
control.
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decreaseinfluorescenceintensity(47).Potential-dependentfluo-
rescence changes generated by DiBAC4(3) are typically 1%
permV (46). A549 cells infected with BUNV exhibited a hyper-
polarised resting membrane potential 6 hpi compared with
uninfected cells, as indicated by the decrease in DiBAC4(3) flu-
orescent intensity (Fig. 5A, 16.23 mV  14 shift). Such a
change is consistent with enhanced K channel activity during
the early stages of BUNV infection. To validate the assay, TEA
(10 mM) and quinidine (200 M) were included during mem-
brane potential measurements and led to depolarization as
would be expected to occur in the face of K channel blockade
(Fig. 5A). Importantly, these effects were reproducible in C6/36
cells where BUNV infection led to a significant reduction in
DiBAC4(3) fluorescence 6 hpi (Fig. 5A, 18.3mV  1.5mV
shift in BUNV cells). To confirm these shifts were K channel
specific, we examined Cl homeostasis during BUNV infection
using the fluorescent indicator N-ethoxycarbonylmethyl-6-
methoxy-quinolinium bromide (MQAE), a dye quenched by
enhanced Cl influx and the subsequent increase in intracellu-
lar chloride concentration [Cl]i. Fig. 5B demonstrates that
BUNV did not affect [Cl]i compared with uninfected A549
cells (p 0.05), consistent with no effects on basally active Cl
conductance. MQAE fluorescence was reduced by treatment
with NPPB and IAA-94 (known Cl channel modulators).
Taken together, these data provide evidence that BUNV specif-
ically alters the functionality of K channels during early stages
of the virus replicative cycle to regulate cellular K flux in both
vertebrate and invertebrate cell lines.
Investigating theK channel Families Required duringBUNV
Infection—Having determined that BUNV cannot establish a
productive infection in the face of K channel blockade, the
molecular identity of the specific K channel(s) required dur-
ing the BUNV lifecycle were investigated. Over 70 different
genes encode K channel subunits in the human genome,
which are divided into subfamilies of voltage-gated K chan-
nels (Kv), calcium-activated K channels (BK), inwardly recti-
fying K channels (Kir) and two-pore K channels (K2p) chan-
nels (48). Quinidine and quinine block specific members of all
of these subfamilies (Fig. 6A) and significantly inhibited
BUNV-N production and reduced the number of BUNV-in-
fected cells (quinidine66.2% 25.7, quinine79.8% 17.0
reduction in BUNV-infected cells, compared with untreated
controls (Fig. 6, B--D, p  0.05). 4-Aminopyridine (4AP), an
inhibitor of Kv channels (49), and barium chloride (BaCl2), an
inhibitor of Kir channels (50, 51), did not impede BUNV infec-
tion suggesting that neither Kv nor Kir activity is required dur-
ing the BUNV lifecycle (Fig. 6,A--D, p 0.05). Consistent with
these findings, cells were protected from BUNV-induced CPE
in a concentration-dependent manner by both quinine and
quinidine, but virus growth was unaffected in the presence of
either 4AP or BaCl2 (Fig. 6E). Similarly SBV growth was
strongly inhibited by quinine and quinidine treatment but was
FIGURE3.K channeldependence isbunyavirus specific.A, A549 cellswere infectedwithHAZV (24h,MOI 1) in thepresenceof the indicated concentrations
of TEA. Lysateswere resolvedbySDS-PAGEandprobedwith sheepanti-HAZVNserum. Blots are representativeof two independent experiments. (ii) Cellswere
assessed for HAZV infection TEA (10mM) by staining fixed cells with sheep anti-HAZV serum and sheep Alexa fluor 594 antibodies. Representative confocal
images are shown. (iii) The%of HAZV-infected cells was assessed TEA treatment fromwidefield images of HAZV-N stained cells. Aminimumof 40 cells were
counted. Results are expressed asmean S.E. (*, significant difference at the p 0.05 level;NS, not significant). B, Vero cells were infectedwith TCID50/ml SBV
in the presence of KCl for 5 days. Cells were fixed in 100% ethanol and stained with 3% (w/v) crystal violet. Representative plates of three independent
experiments are shown. C (i) A549 cells were infected with hRSV (24 h, MOI 1)  the indicated concentrations of TEA or ribavirin. Lysates were resolved by
SDS-PAGE and probed with goat anti-hRSV antibodies (n 3). Blots were reprobed for GAPDH as a loading control. Lanes shown are from the same gel and
representative of three independent experiments. (ii) A549 cells were infected with hRSV  10 mM TEA and the % of hRSV-infected cells assessed by
immunofluorescence through staining with goat anti-hRSV antibodies and anti-goat Alexa fluor 594 antibodies. Representative confocal images are shown.
(iii) Cells treated as in (ii) were assessed for the % of infected cells by FACs analysis. Results are the average of two independent experiments. Values are
normalized to infected no-drug controls. Results are expressed as mean S.E. (*, significant difference at the p 0.05 level; NS, not significant).
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unaffected by 4AP or BaCl2 (data not shown). Modulation of
Ca2-activated K channels (Tram 34), ATP-sensitive K
channels (Glibenclamide) and G-protein-coupled Kir channels
(Ifenprodil) also did not influence BUNV-N production sug-
gesting these K channel family members do not contribute to
BUNV growth (Fig. 6,A–D). Time-of-addition experiments for
quinidine (Fig. 6F) additionally confirmed the drug inhibits
BUNV at an identical stage to that observed for TEA (Fig. 5C);
quinidine inhibited BUNV-Nproductionwhen administered at
0 to 4 hpi and a recovery of BUNV-N production occurred
when administered  6 hpi (Fig. 6F, compare lanes 1, 6–8).
Taken together, these data suggest that BUNV requires the
FIGURE 4.K channel activity is required at an early post-entry stageof BUNV infection.A(i), cells were infectedwith BUNV in the presence of TEA (10mM)
ormonensin (20M) for 1 h. Cells werewashedwith PBS 0.5% trypsin to remove cell attached viruses and cells incubated for a further 24 h inmedium alone.
BUNV-N expression as a marker of BUNV infection was assessed byWestern blot analysis (i), densitometry (ii), and immunofluorescence (B). C, TEA was added
at the indicated time points post-BUNV infection and BUNV-N expression assessed by Western blot analysis 24 h post-infection. Unt (untreated) is no drug
included during the time course, T x indicates the inclusion of TEA throughout the time course of BUNV infection (n 3). D, to assess BUNV RNA synthesis,
BSRT7 cells were transfectedwith cDNAplasmids encoding BUNV S and L segment ORFs, and amodel negative sense RNA segment that contained conserved
BUNV 3	 and 5	 non-translated regions flanking the Renilla luciferase ORF. Cells were incubated with or without 10 mM TEA, and 18 h post transfection cell
lysateswere analyzed for luciferase activity (RLUper second) as ameasureof BUNVgeneexpression. The LORFplasmidwasomitted to act as anegative control
to measure non-BUNV mediated luciferase expression. Results were calculated relative to those for an untreated control. Error bars represent the standard
errors of the means (S.E.) of results from three independent experiments performed in duplicate. NS, no differences at a significance level of 0.05.
FIGURE5.BUNVhyperpolarises themembranepotential throughK channel activation.A (i) A549or (ii) C6/36 cells infectedwithBUNV (MOI 1), or treated
with TEA (10mM)/quinidine (200M)were exposed to themembrane potential sensitive fluorescent dyeDiBAC4 (3) (20M). Values represent 6 hpi/treatment
and are normalized to untreated controls (n 3). Results are expressed as the mean fluorescence per well S.E. of averaged widefield images (*, significant
difference fromuntreated cells at the p 0.05 level). Data are representative of at least three independent experiments. B, A549 cells infectedwith BUNV (MOI
1) or treated with NPPB (10 M)/IAA-94 (100 M) were exposed to MQAE. Fluorescence was acquired as in Fig. 5A. Values represent 6 hpi/treatment and are
normalized to untreated controls (n 3). Results are expressed as themean fluorescence perwell S.E. of averagedwidefield images (*, significant difference
from untreated cells at the p 0.05 level). Data are representative of three independent experiments.
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function of quinine- and quinidine-sensitive host cell K chan-
nel(s) that are unlikely to be members of the Kv, BK, and Kir
families. Given the lack of effect of Kv, BK, and Kir modulation
on BUNV infection, the role of the K2P channel superfamily
during the BUNV lifecycle were investigated (52–54). In mam-
mals, seventeen K2P channel genes have been identified and the
expression of 12 of these members (KCNK 1–7, 9, 10, 13, 15,
and 17) were detected in A549 cells by RT-PCR analysis con-
firming their potential involvement in the BUNV lifecycle (Fig.
7A(i)). Protein expression was further confirmed for KCNK1,
FIGURE 6. Investigating the K channel families required during BUNV infection. A, table detailing the K channel modulating compounds assessed for
their effects on BUNV. B, BUNV-infected A549 cells (24h, MOI 1) were treated with the indicated concentrations of K channel modulators. Lysates were
resolved by SDS-PAGE and probedwith sheep anti-BUNVN serum. C, cells treatedwith quinidine (200 M), quinine (200 M), 4AP (1mM), BaCl2 (2mM), Tram 34 (3
M), glibenclamide (20M), and ifenprodil (30m) during the 24-h infection period were fixed, permeabilized, and stained for DAPI (blue) and BUNV-N (red) as
in Fig. 1. D, % of BUNV infected cells was assessed for each treatment fromwidefield images of BUNV-N stained cells (gray bars). A minimum of 100 cells were
counted from at least three independent experiments. ATPlite assays were performed for each drug treatment for 24 h and normalized to no-drug controls to
assess cell viability (black bars). Results are expressed as mean S.E. (*, significant difference at the p 0.05 level). E, TCID50/ml BUNV assays were performed
for selected drug treatments as in Fig. 2D. Representative plates of three independent experiments are shown. F, quinidine was added at the indicated time
points post-BUNV infection and BUNV-N expression assessed byWestern blot analysis 24 h post-infection.Unt is no drug included during the time course, T
0 indicates the inclusion of quinidine throughout the time course of BUNV infection (n 3).
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KCNK2, KCNK7, and KCNK9 by immunofluorescent staining
(Fig. 7A(ii)). K2P channels are distinguished by the presence of
two K pores arranged in tandem, sensitivity to quinine and
quinidine, and a relatively poorly defined pharmacology com-
pared with other K family members (52, 55, 56). However,
certain organic compounds have proven useful to indicate
physiological roles of many K2P family members (Fig. 7B). The
organic polycations ruthenium red (RuR) and spermine can
directly block specific K2P channels through the interaction
with negatively-charged residues in the K2P pore domains (52,
57). Both compounds inhibited BUNV-N production in a
concentration-dependent manner (Fig. 7C) and significantly
reduced the percentage of BUNV-infected cells (RuR (50 M)
82.1% 15.21 reduction, spermine (500M)88.5% 16.61
reduction, p  0.05), compared with untreated controls (Fig.
7D (i-ii) gray bars) with no cytotoxicity at the highest concen-
tration used (Fig. 7D (ii) black bars). In addition, drugs
approved by the U.S. Food and Drug Administration (FDA),
including bupivacaine (local anesthetic), haloperidol (antipys-
chotic), and fluoxetine (anti-depressant), similarly inhibited
BUNV-N production and reduced the percentage of BUNV-
infected cells at concentrations reported as inhibitory to K2P
channels (bupivacaine (150M)76.8% 27.9, haloperidol (20
M)76.3% 22.4 inhibition, fluoxetine (30M)87.2% 8.9
inhibition), (Fig. 7,C andD, p 0.05) (52, 56, 58).We addition-
ally observed inhibition of BUNV by curcumin and genistein,
both of which are known blockers of K2P members (data not
shown). These findings implicate K2P channels as the K chan-
nel familymember required by BUNVduring the early stages of
virus infection.
Discussion
Ion channels underpin an array of essential cellular processes
and drugs acting on specific ion channels are the treatment of
choice for many diseases (48). Using the available pharmaco-
logical tools targeting various cellular ion channels, this study
showed that K channel function is critical to the growth of
BUNV (Figs. 1–2), the prototypic bunyavirus in both vertebrate
and invertebrate cells. K channel dependence was also
observedwithHAZVand SBV, revealing this as a key virus-host
interaction across other bunyaviruses (Fig. 3), suggesting itmay
be a general property that applies to all family members.
FIGURE 7. Two-pore potassium channel blockers inhibit BUNV infection. A(i), RT-PCR demonstrates that several K2P channels are expressed in A549 cells.
Templates for the reactions were derived from uninfected A549 cells. Negative control reactions lacked template during amplification. Identical results were
obtained with at least two additional preparations of RNA. GAPDHwas included as a control. (ii) Indicated K2P channels were assessed for expression in A549
cells through immunofluorescent analysis. Representative confocal images are shown. B, table detailing the K2P modulating compounds investigated during
the study. C, BUNV-infected A549 cells (24 h, MOI 1) were treated with a range of compounds shown previously to inhibit members of the K2P channel family.
Lysateswere resolved by SDS-PAGE and probedwith sheep anti-BUNV-N serum.D(i), cells treatedwith RuR (50M), spermine (500M), bupavacaine (150M),
haloperidol (20 M), and fluoxetine (30 M) were infected as in B and fixed, permeabilized, and stained for DAPI (blue) and BUNV-N (red). (ii) The % of BUNV
infected cells was assessed for each treatment from widefield images of BUNV-N stained cells (gray bars). A minimum of 100 cells were counted from three
independent experiments. ATPlite assays were performed for each drug treatment and normalized to untreated controls to assess cell viability (black bars).
Results are expressed as mean S.E. (*, significant difference at the p 0.05 level).
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It is not clear why the BUNV replicative cycle is dependent
upon manipulation of host cell K channel currents. Previous
reliance of bunyavirus replication had been noted by Frugul-
hetti and Rebello (59), who reported that changes in K ion
concentrations disrupted the growth of the orthobunyavirus
Marituba virus. The stage of the life cycle affected was found to
be mRNA translation, although the mechanism that under-
pinned this dependence was not pursued, and the role of cellu-
lar ion channels in this process was not investigated. In the
present study, K channelmodulation had no discernible effect
on mRNA transcription and translation in the context of the
BUNVminireplicon system (Fig. 4C) and sowe suggest that our
findings of K channel reliance are likely unrelated to these
early findings. To better understand the nature of the K chan-
nel requirement, time of addition assays were performedwhich
indicated that the K sensitive steps in the BUNV life cycle
occur within the initial 6 h of virus infection, but do not include
virus binding/entry (Fig. 4, A and B). It is thus most likely that
K channel modulation contributes to early events within the
virus life cycle including virus uncoating and/or events prior to
the formation of RNA replication factories, postulated to
assemble around the Golgi (60–62).
A key finding of this study is that K2P channels are the K
familymember required for BUNV infection. BUNVwas inhib-
ited by diverse pharmacological agents thatmodulateK2P chan-
nels (52, 57, 58, 63, 64), but no effects of K channelmodulators
targeting Kv, BK, and Kir channels was observed. The family of
K2P channels is small containing only 17 members, which
regulate the membrane potential of both “excitable” and “non-
excitable” cells (58). K2P channels respond to a diverse array of
stimuli including pH, temperature and membrane stretch and
their pharmacology is highly characteristic, as a result of their
distinct structural features (55, 56, 65). Using a fluorescent
membrane potential probe, hyperpolarization of the plasma
membranewas observed in BUNV-infected cells 6 hpi (Fig. 4), a
shift consistentwith an enhancement of K2P activity at the stage
of the virus lifecycle sensitive to K channel modulation. Many
viruses encode their own viroporin (reviewed in Ref. 66), which
are pore forming proteins that have been documented to par-
ticipate in several viral functions, including the promotion of
release of virus particles, modulation of cellular vesicles, glyco-
protein trafficking, and membrane permeability. As BUNV has
no known viroporin, it is possible that BUNV proteins have
evolved to interfere and depend on cellular K2P channels to aid
virus pathogenesis. While we do not understand the mecha-
nism(s) of K2P activation, our findings implicate BUNV struc-
tural proteins present in the virion to mediate these effects
since viral gene expression would not have occurred at these
timepoints, and thus no new proteins would be generated.
Orthobunyaviruses have been shown to enter cells via clathrin
mediated endocytosis (44), but events post-entry are less well
understood, although virion trafficking of CCHFV has been
shown to be ESCRT dependent (67). The modulation/reliance
upon host cell ion K2P channels at this post-entry stage is con-
sistent with recent observations for other negative sense envel-
oped viruses. Post-entry trafficking of Ebola virus, a single
stranded negative sense RNA virus, is dependent upon endo-
somal calcium channels termed two-pore channels (TPCs)
(26). In addition the capsid (C) protein of dengue virus, a single-
stranded positive sense RNA virus, forms an association with
lipidmembranes that is intrinsically dependent on the intracel-
lular concentrations of K ions (68). The cellular mechanisms
of these ion-channel dependent events remain to be elucidated.
As HAZV represents a model for CCHFV (41), a cause of a
severe, often fatal disease in humans, this study highlights the
potential of K channel modulating drugs as a novel therapeu-
tic intervention against more dangerous pathogens of this fam-
ily. It is interesting to note that compounds such as haloperidol
and fluoxetine possess highly desirable drug properties in a
clinical setting; good oral bioavailability (60–70%), generally
well tolerated with severe side effects uncommon and the abil-
ity to cross the blood brain barrier (63, 69). This may be perti-
nent for bunyavirus treatment since BUNV infection in both
mouse and horses is largely neurotropic (70, 71). Indeed BUNV
infection was permissive in U87-MG cells; a human primary
glioblastoma cell line, and could be inhibited by K channel
modulation (Fig. 2).
In conclusion, despite encompassing a large number of
viruses capable of causing outbreaks that would impact public
health, national economies and food security; little is known
regarding key stages in the life cycle of bunyaviruses. This study
has demonstrated the importance ofK channel activity during
the BUNV lifecycle and contributes to the growing field of viral
ion channel interactions. Targeting these K channels in
patients infected with severe Bunyaviridae infections may
therefore represent a new prospect for future anti-viral drug
development.
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